TheStreet downgraded shares of Kewaunee Scientific (NASDAQ:KEQU) from a b- rating to a c+ rating in a report published on Thursday morning, TheStreetRatingsTable reports.
Separately, ValuEngine downgraded shares of Kewaunee Scientific from a buy rating to a hold rating in a research note on Friday, December 28th.
KEQU opened at $21.40 on Thursday. The stock has a market capitalization of $58.85 million, a PE ratio of 13.80 and a beta of -0.59. Kewaunee Scientific has a 1 year low of $20.21 and a 1 year high of $38.80. The company has a quick ratio of 1.82, a current ratio of 2.52 and a debt-to-equity ratio of 0.01.
Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Tuesday, February 26th. The technology company reported ($0.01) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.56 by ($0.57). Kewaunee Scientific had a net margin of 2.71% and a return on equity of 8.69%.
The company also recently declared a quarterly dividend, which was paid on Monday, March 25th. Investors of record on Monday, March 11th were given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 3.55%. The ex-dividend date of this dividend was Friday, March 8th.
A number of hedge funds and other institutional investors have recently made changes to their positions in KEQU. Eagle Ridge Investment Management purchased a new stake in Kewaunee Scientific during the 4th quarter valued at $282,000. North Star Investment Management Corp. increased its holdings in shares of Kewaunee Scientific by 7.2% in the 4th quarter. North Star Investment Management Corp. now owns 90,692 shares of the technology company’s stock worth $3,015,000 after purchasing an additional 6,063 shares in the last quarter. FMR LLC raised its stake in shares of Kewaunee Scientific by 120.6% in the third quarter. FMR LLC now owns 24,597 shares of the technology company’s stock worth $775,000 after purchasing an additional 13,447 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Kewaunee Scientific by 1.3% in the third quarter. Dimensional Fund Advisors LP now owns 211,859 shares of the technology company’s stock worth $6,674,000 after purchasing an additional 2,639 shares during the last quarter. Finally, BlackRock Inc. lifted its holdings in shares of Kewaunee Scientific by 125.3% during the third quarter. BlackRock Inc. now owns 28,088 shares of the technology company’s stock valued at $885,000 after purchasing an additional 15,620 shares in the last quarter. Institutional investors own 50.07% of the company’s stock.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company operates in two segments, Domestic and International. Its products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Further Reading: How to Invest in a Bull Market
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.